'Prodromal diagnosis' of psychosis: An impartial commentary

Australian and New Zealand Journal of Psychiatry

Volumn 45, Issue 7, 2011, Pages 520-523

  Jorm, Anthony F ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL EVALUATION; CLINICAL PRACTICE; COGNITIVE THERAPY; DISEASE COURSE; DISEASE SEVERITY; EDUCATION; HEALTH CARE ORGANIZATION; HIGH RISK PATIENT; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRODROME; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SYMPTOM;

EARLY DIAGNOSIS; HUMANS; PSYCHOTIC DISORDERS;

EID: 79959881228     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2011.585132     Document Type: Review

References (13)

1. Rosenman S, Anderson P. Does prodromal diagnosis delay early intervention? Aust NZ J Psychiatry 2011; 45:509-514.
2. McGorry PD. Pre-emptive intervention in psychosis: agnostic rather than diagnostic. Aust NZ J Psychiatry 2011; 45:515-519.
3. Correll CU, Hauser M, Auther AM, Cornblatt BA. Research in people with psychosis risk syndrome: a review of the currentevidence and future directions. J Child Psychol Psychiatry 2010; 51:390-431.
4. Yung AR, Nelson B. Young people at ultra high risk for psychosis: a research update. Early Interv Psychiatry 2011; 5:S52 - 57.
5. McGorry P, Killackey E, Lambert T e t al . Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust NZ J Psychiatry 2005; 39:1-30. (Pubitemid 40282556)
6. Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010; 123:199-207.
7. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust NZ J Psychiatry 2006; 40:616-622. (Pubitemid 43984963)
8. Frances A. Opening Pandora ' s box: the 19 worst suggestions for DSM5. Psychiatric Times 11 February 2010, www.psychiatrictimes . com/dsm/content/ article/10168/1522341.
9. Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010; 123:30-36.
10. Moncrieff J. Questioning the 'neuroprotective ' hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? Br J Psychiatry 2011; 198:85-87.
11. Amminger GP, Schafer MR, Papageorgiou K e t al . Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67:146-154.
12. Rose G. Strategy of prevention: lessons from cardiovascular disease Br Med J (Clin Res Ed) 1981; 282:1847-1851. (Pubitemid 11047749)
13. Cantor-Graae E. The contribution of social factors to the development of schizophrenia: a review of recent fi ndings. Can J Psychiatry 2007; 52:277-286. (Pubitemid 46743456)